121 related articles for article (PubMed ID: 20369284)
1. Coexpression of atypical chemokine binders (ACBs) in breast cancer predicts better outcomes.
Zeng XH; Ou ZL; Yu KD; Feng LY; Yin WJ; Li J; Shen ZZ; Shao ZM
Breast Cancer Res Treat; 2011 Feb; 125(3):715-27. PubMed ID: 20369284
[TBL] [Abstract][Full Text] [Related]
2. Absence of multiple atypical chemokine binders (ACBs) and the presence of VEGF and MMP-9 predict axillary lymph node metastasis in early breast carcinomas.
Zeng XH; Ou ZL; Yu KD; Feng LY; Yin WJ; Li J; Shen ZZ; Shao ZM
Med Oncol; 2014 Sep; 31(9):145. PubMed ID: 25097078
[TBL] [Abstract][Full Text] [Related]
3. Atypical chemokine receptors predict lymph node metastasis and prognosis in patients with cervical squamous cell cancer.
Hou T; Liang D; Xu L; Huang X; Huang Y; Zhang Y
Gynecol Oncol; 2013 Jul; 130(1):181-7. PubMed ID: 23603371
[TBL] [Abstract][Full Text] [Related]
4. Prognostic impact of atypical chemokine receptor expression in patients with gastric cancer.
Zhu Z; Sun Z; Wang Z; Guo P; Zheng X; Xu H
J Surg Res; 2013 Jul; 183(1):177-83. PubMed ID: 23462454
[TBL] [Abstract][Full Text] [Related]
5. Host genotype and tumor phenotype of chemokine decoy receptors integrally affect breast cancer relapse.
Yu KD; Wang X; Yang C; Zeng XH; Shao ZM
Oncotarget; 2015 Sep; 6(28):26519-27. PubMed ID: 26314842
[TBL] [Abstract][Full Text] [Related]
6. Involvement of a novel chemokine decoy receptor CCX-CKR in breast cancer growth, metastasis and patient survival.
Feng LY; Ou ZL; Wu FY; Shen ZZ; Shao ZM
Clin Cancer Res; 2009 May; 15(9):2962-70. PubMed ID: 19383822
[TBL] [Abstract][Full Text] [Related]
7. [Duffy antigen receptor for chemokines attenuates breast cancer growth and metastasis: an experiment with nude mice].
Wang J; Ou ZL; Hou YF; Luo JM; Chen Y; Zhou J; Shen ZZ; Ding J; Shao ZM
Zhonghua Yi Xue Za Zhi; 2005 Aug; 85(29):2033-7. PubMed ID: 16313795
[TBL] [Abstract][Full Text] [Related]
8. Enhanced expression of Duffy antigen receptor for chemokines by breast cancer cells attenuates growth and metastasis potential.
Wang J; Ou ZL; Hou YF; Luo JM; Shen ZZ; Ding J; Shao ZM
Oncogene; 2006 Nov; 25(54):7201-11. PubMed ID: 16785997
[TBL] [Abstract][Full Text] [Related]
9. [Downregulation of Duffy antigen receptor for chemokine (DARC) is associated with lymph node metastasis in human breast cancer].
Ou ZL; Wang J; Hou YF; Luo JM; Shen ZZ; Shao ZM
Zhonghua Zhong Liu Za Zhi; 2006 Aug; 28(8):586-9. PubMed ID: 17236552
[TBL] [Abstract][Full Text] [Related]
10. The atypical chemokine receptor CCX-CKR regulates metastasis of mammary carcinoma via an effect on EMT.
Harata-Lee Y; Turvey ME; Brazzatti JA; Gregor CE; Brown MP; Smyth MJ; Comerford I; McColl SR
Immunol Cell Biol; 2014 Nov; 92(10):815-24. PubMed ID: 25027038
[TBL] [Abstract][Full Text] [Related]
11. Chemokine decoy receptor d6 plays a negative role in human breast cancer.
Wu FY; Ou ZL; Feng LY; Luo JM; Wang LP; Shen ZZ; Shao ZM
Mol Cancer Res; 2008 Aug; 6(8):1276-88. PubMed ID: 18708360
[TBL] [Abstract][Full Text] [Related]
12. Coy decoy with a new ploy: interceptor controls the levels of homeostatic chemokines.
Haraldsen G; Rot A
Eur J Immunol; 2006 Jul; 36(7):1659-61. PubMed ID: 16791884
[TBL] [Abstract][Full Text] [Related]
13. Levels of hypoxia-inducible factor-1alpha independently predict prognosis in patients with lymph node negative breast carcinoma.
Bos R; van der Groep P; Greijer AE; Shvarts A; Meijer S; Pinedo HM; Semenza GL; van Diest PJ; van der Wall E
Cancer; 2003 Mar; 97(6):1573-81. PubMed ID: 12627523
[TBL] [Abstract][Full Text] [Related]
14. Epithelial periostin expression is correlated with poor survival in patients with invasive breast carcinoma.
Kim GE; Lee JS; Park MH; Yoon JH
PLoS One; 2017; 12(11):e0187635. PubMed ID: 29161296
[TBL] [Abstract][Full Text] [Related]
15. Silent chemoattractant receptors: D6 as a decoy and scavenger receptor for inflammatory CC chemokines.
Locati M; Torre YM; Galliera E; Bonecchi R; Bodduluri H; Vago G; Vecchi A; Mantovani A
Cytokine Growth Factor Rev; 2005 Dec; 16(6):679-86. PubMed ID: 15996892
[TBL] [Abstract][Full Text] [Related]
16. p53 as an independent prognostic marker in lymph node-negative breast cancer patients.
Silvestrini R; Benini E; Daidone MG; Veneroni S; Boracchi P; Cappelletti V; Di Fronzo G; Veronesi U
J Natl Cancer Inst; 1993 Jun; 85(12):965-70. PubMed ID: 8496982
[TBL] [Abstract][Full Text] [Related]
17. Expression of Duffy antigen receptor for chemokines (DARC) is down-regulated in colorectal cancer.
Zhou S; Liu M; Hu Y; An W; Liang X; Yu W; Piao F
J Recept Signal Transduct Res; 2015; 35(5):462-7. PubMed ID: 26096170
[TBL] [Abstract][Full Text] [Related]
18. Regulation of breast cancer metastasis by atypical chemokine receptors.
Cheng X; Hung MC
Clin Cancer Res; 2009 May; 15(9):2951-3. PubMed ID: 19383808
[TBL] [Abstract][Full Text] [Related]
19. [Interceptors:--"silent" chemokine receptors].
Grodecka M; Waśniowska K
Postepy Hig Med Dosw (Online); 2007; 61():231-9. PubMed ID: 17507871
[TBL] [Abstract][Full Text] [Related]
20. Expression of matrix metalloproteinase (MMP)-2 and MMP-9 in breast cancer with a special reference to activator protein-2, HER2, and prognosis.
Pellikainen JM; Ropponen KM; Kataja VV; Kellokoski JK; Eskelinen MJ; Kosma VM
Clin Cancer Res; 2004 Nov; 10(22):7621-8. PubMed ID: 15569994
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
